RARE DISEASES A–Z · LETTER M
Myotonic Dystrophy
Myotonic dystrophy is the most common muscular dystrophy of adult life — and much more than a muscle disease. Its hallmark is myotonia, an inability of muscle to relax promptly after contraction, but the same genetic fault also reaches the heart, eyes, hormones, gut, and brain.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
Type 1 is caused by an expanding CTG repeat in the DMPK gene; type 2 by a similar expansion in another gene (CNBP). The expansions produce toxic RNA that disrupts how many other genes are spliced — a systems-wide fault, which is why so many organs are involved. The signature is myotonia: after gripping, the hand opens slowly; after a tap, muscle stays contracted. Weakness has a distinctive pattern — face, jaw, neck, forearms, hands, and ankles rather than the big shoulder and hip muscles. Cataracts develop early (a particular rainbow-like cataract is a clue), the heart's conduction system scars (causing rhythm problems that are the main cause of early death), and diabetes, thyroid problems, gallstones, bowel dysmotility, excessive daytime sleepiness, and apathy or cognitive change are all common. The congenital form, from a greatly expanded repeat inherited from the mother, causes severe weakness and breathing problems at birth.
How it works
Diagnosis is genetic: a blood DNA test measuring the repeat expansion in DMPK (type 1) or CNBP (type 2) is definitive, and expansion size roughly correlates with severity and age of onset. Electrical muscle studies (EMG) show the characteristic myotonic discharges — the 'dive-bomber' sound on the speaker. Because the condition hides in plain sight, the work-up also catalogues its systems: ECG and rhythm monitoring for the heart, eye examination for cataracts, blood sugar and thyroid tests, and sleep assessment. Family testing is offered with genetic counselling, and the anticipation phenomenon — expansions growing between generations — is explained carefully, since it changes what parents and children can expect.
Day to day
No treatment yet corrects the toxic RNA, though gene-targeted therapies are in development. Care is organised surveillance plus treating each system: cardiac pacing or defibrillator devices when conduction disease demands it; cataract surgery when vision suffers; diabetes and thyroid treatment as usual; and medicines for specific symptoms — mexiletine can ease troublesome myotonia in type 1 (after heart checks), and wakefulness agents help some with disabling sleepiness. Physiotherapy maintains mobility, orthotics support weak ankles, and speech and swallowing review protects nutrition. Anaesthesia requires an informed team and a plan. With systematic surveillance — especially of the heart — outcomes have improved, and registries help families access trials of the emerging RNA-targeted treatments.
When to get help
Annual review in a neuromuscular clinic should include an ECG (with rhythm monitoring if indicated), eye, diabetes, and thyroid checks, and a review of sleepiness, mood, and swallowing. Tell every anaesthetist about the diagnosis — people with myotonic dystrophy are unusually sensitive to sedatives and some anaesthetic drugs, and post-operative breathing complications are a known risk; many carry an alert card. Report palpitations, fainting, or blackouts urgently — rhythm problems can be silent until they are not. Driving safety must be reviewed honestly where sleepiness is severe. Genetic counselling supports family planning, including prenatal and embryo testing options.
Common questions
Why is it worse in my child than in me?
Anticipation: because the DNA repeat is unstable, it tends to lengthen when passed from parent to child, so the disease starts earlier and is more severe in the next generation. The effect is strongest from the mother, which is how the congenital form arises.
Can it affect the heart without symptoms?
Yes — one of the condition's traps. The heart's electrical system is affected by the same process, causing conduction delays and rhythm disturbances that can be fatal yet cause no symptoms until a collapse. Regular ECGs and heart monitoring are recommended even when you feel entirely well.
Is there a treatment for the stiffness itself?
Mexiletine — a medicine that stabilises muscle membranes — has trial evidence for improving hand relaxation in type 1, though it needs heart screening first because of its rhythm effects. Wakefulness medicines help some people with severe sleepiness. Much of management, though, is surveillance.
Is myotonic dystrophy the same as myotonia congenita?
Myotonia is also a feature of a separate group — the non-dystrophic myotonias (muscle channelopathies) — in which there is stiffness without progressive weakness or the other organ involvement. Myotonic dystrophy is distinguished by weakness plus the heart, eye, hormone, and brain effects.
More in Letter M
Related
Sources
- Myotonic Dystrophy — MedlinePlus Genetics (MedlinePlus)
- Myotonic Dystrophy — Genetic and Rare Diseases Information Center (NIH GARD)
- Myotonic Dystrophy (Muscular Dystrophy Association)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Heart rhythm monitoring and anaesthesia precautions are individual; follow your neuromuscular team's plan.